| Authors: |
Suzon B; Department of Internal Medicine, Martinique University Hospital, Fort-de-France, Martinique, France; EpiCliV Research Unit, University of French West Indies, Fort-de-France, Martinique, France., Goulabchand R; Department of Internal Medicine, Nîmes University Hospital, France; Institute for Regenerative Medicine and Biotherapy, INSERM U1183, Montpellier, France., Louis-Sidney F; EpiCliV Research Unit, University of French West Indies, Fort-de-France, Martinique, France; Department of Rheumatology, Martinique University Hospital, France., Maria A; Institute for Regenerative Medicine and Biotherapy, INSERM U1183, Montpellier, France; Department of Internal Medicine and Immuno-Oncologie (MedI(2)O), Montpellier University Hospital, France; Montpellier-1 University, Faculty of Medicine, France., Najjari R; Department of Internal Medicine and Multi-Organic Diseases, Montpelier University Hospital, France., Chauvet E; Department of Internal Medicine and Multi-Organic Diseases, Montpelier University Hospital, France., Le Quellec A; Department of Internal Medicine and Multi-Organic Diseases, Montpelier University Hospital, France., Bessis D; Department of Dermatology, Montpellier University Hospital, France., Guilpain P; Institute for Regenerative Medicine and Biotherapy, INSERM U1183, Montpellier, France; Montpellier-1 University, Faculty of Medicine, France; Department of Internal Medicine and Multi-Organic Diseases, Montpelier University Hospital, France. Electronic address: p-guilpain@chu-montpellier.fr. |